Advertisement

Image-Guided Radiation Therapy for Renal Cell Carcinoma

  • Ying Li
  • Gregory P. Swanson
  • Chul S. Ha
Reference work entry

Abstract

The role of radiotherapy in treating renal cell carcinoma (RCC) was thought to be limited for several reasons. RCC was considered to be radioresistant, and clinical data on preoperative or postoperative radiotherapy did not show significant benefits. In recent years, stereotactic body radiation therapy (SBRT) using image guidance has emerged as a favorable radiation technique in treating RCC. This chapter reviews the radiobiology of RCC and clinical experience with hypofractionated radiotherapy and SBRT in palliating metastatic RCC and definitively treating primary RCC.

Keywords

Renal Cell Carcinoma Renal Cell Cancer Stereotactic Body Radiation Therapy Radiation Therapy Oncology Group Biologically Effective Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    NCCN, Kidney cancer. Version 1. 2013, National Comprehensive Cancer Network clinical practice guidelines in oncology.Google Scholar
  2. 2.
    McLaughlin JK, Lipworth L, Tarone RE. Epidemiologic aspects of renal cell carcinoma. Semin Oncol. 2006;33(5):527–33.CrossRefPubMedGoogle Scholar
  3. 3.
    Homma Y, et al. Increased incidental detection and reduced mortality in renal cancer–recent retrospective analysis at eight institutions. Int J Urol. 1995;2(2):77–80.CrossRefPubMedGoogle Scholar
  4. 4.
    Cox CE, et al. Renal adenocarcinoma: 28-year review, with emphasis on rationale and feasibility of preoperative radiotherapy. J Urol. 1970;104(1):53–61.PubMedGoogle Scholar
  5. 5.
    Kortmann RD, et al. Future strategies in external radiation therapy of renal cell carcinoma. Anticancer Res. 1999;19(2C):1601–3.PubMedGoogle Scholar
  6. 6.
    Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995;31(5):1249–56.CrossRefPubMedGoogle Scholar
  7. 7.
    Kjaer M, Frederiksen PL, Engelholm SA. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group. Int J Radiat Oncol Biol Phys. 1987;13(5):665–72.CrossRefPubMedGoogle Scholar
  8. 8.
    Waters CA, Frontz WA. Radiation therapy of renal cortical neoplasms. South Med J. 1934;27:290–9.CrossRefGoogle Scholar
  9. 9.
    Bloom HJ. Adjuvant therapy for adenocarcinoma of the kidney: present position and prospects. Br J Urol. 1973;45(3):237–57.CrossRefPubMedGoogle Scholar
  10. 10.
    Caldwell W. Principles of radiation therapy. In: Javadpour N, editor. Principles and management of urologic cancer. 2nd ed. Baltimore: Williams & Wilkins; 1983.Google Scholar
  11. 11.
    Vaeth JM. Proceedings: cancer of the kidney–radiation therapy and its indications in non-Wilms’ tumors. Cancer. 1973;32(5):1053–5.CrossRefPubMedGoogle Scholar
  12. 12.
    van der Werf-Messing B. Proceedings: carcinoma of the kidney. Cancer. 1973;32(5):1056–61.CrossRefPubMedGoogle Scholar
  13. 13.
    Juusela H, et al. Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol. 1977;11(3):277–81.CrossRefPubMedGoogle Scholar
  14. 14.
    Finney R. The value of radiotherapy in the treatment of hypernephroma–a clinical trial. Br J Urol. 1973;45(3):258–69.CrossRefPubMedGoogle Scholar
  15. 15.
    Kjaer M, et al. A randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. A study by the Copenhagen Renal Cancer Study Group. Scand J Urol Nephrol. 1987;21(4):285–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Stein M, et al. The value of postoperative irradiation in renal cell cancer. Radiother Oncol. 1992;24(1):41–4.CrossRefPubMedGoogle Scholar
  17. 17.
    Tunio MA, Hashmi A, Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol. 2010;21(9):1839–45.CrossRefPubMedGoogle Scholar
  18. 18.
    Rubin P. Clinical radiation pathology, vol. II. Philadelphia: WB Saunders & Co; 1968.Google Scholar
  19. 19.
    Deacon J, Peckham MJ, Steel GG. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 1984;2(4):317–23.CrossRefPubMedGoogle Scholar
  20. 20.
    Fertil B, Malaise EP. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys. 1981;7(5):621–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Ning S, et al. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer. 1997;80(12 Suppl):2519–28.CrossRefPubMedGoogle Scholar
  22. 22.
    Chiou RK, et al. Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using a nude mouse model. Cancer. 1988;61(9):1766–75.CrossRefPubMedGoogle Scholar
  23. 23.
    Weichselbaum RR, Nove J, Little JB. X-ray sensitivity of human tumor cells in vitro. Int J Radiat Oncol Biol Phys. 1980;6(4):437–40.CrossRefPubMedGoogle Scholar
  24. 24.
    Wei K, Wandl E, Karcher KH. X-ray induced DNA double-strand breakage and rejoining in a radiosensitive human renal carcinoma cell line estimated by CHEF electrophoresis. Strahlenther Onkol. 1993;169(12):740–4.PubMedGoogle Scholar
  25. 25.
    Saksela E, Alfthan O, Malmio K. Effect of preoperative radiotherapy on the growth of human renal carcinoma tissue in vitro. Scand J Urol Nephrol. 1973;7(2):181–3.CrossRefPubMedGoogle Scholar
  26. 26.
    Otto U, et al. Transplantation of human renal cell carcinoma into NMRI nu/nu mice. III. Effect of irradiation on tumor acceptance and tumor growth. J Urol. 1985;134(1):170–4.CrossRefPubMedGoogle Scholar
  27. 27.
    Deschavanne PJ, Fertil B. A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys. 1996;34(1):251–66.CrossRefPubMedGoogle Scholar
  28. 28.
    DiBiase SJ, et al. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol. 1997;158(3 Pt 1):746–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Walsh L, et al. Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol. 2006;50(4):795–800.CrossRefPubMedGoogle Scholar
  30. 30.
    Ponsky LE, et al. Initial evaluation of Cyberknife technology for extracorporeal renal tissue ablation. Urology. 2003;61(3):498–501.CrossRefPubMedGoogle Scholar
  31. 31.
    Reddy S, et al. The role of radiation therapy in the palliation of metastatic genitourinary tract carcinomas. A study of the Radiation Therapy Oncology Group. Cancer. 1983;52(1):25–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Halperin EC, Harisiadis L. The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer. 1983;51(4):614–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Fossa SD, Kjolseth I, Lund G. Radiotherapy of metastases from renal cancer. Eur Urol. 1982;8(6):340–2.PubMedGoogle Scholar
  34. 34.
    Seitz W, Karcher KH, Binder W. Radiotherapy of metastatic renal cell carcinoma. Semin Surg Oncol. 1988;4(2):100–2.PubMedGoogle Scholar
  35. 35.
    Wilson D, et al. The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma. Clin Oncol (R Coll Radiol). 2003;15(7):400–7.CrossRefGoogle Scholar
  36. 36.
    Lee J, et al. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer. 2005;104(9):1894–900.CrossRefPubMedGoogle Scholar
  37. 37.
    Freundt K, et al. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors. Strahlenther Onkol. 2010;186(4):218–23.CrossRefPubMedGoogle Scholar
  38. 38.
    Sundaresan N, et al. Surgical treatment of spinal cord compression in kidney cancer. J Clin Oncol. 1986;4(12):1851–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Rades D, et al. Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. Int J Radiat Oncol Biol Phys. 2011;80(5):1492–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Reichel LM, et al. Radiotherapy to bone has utility in multifocal metastatic renal carcinoma. Clin Orthop Relat Res. 2007;459:133–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Onufrey V, Mohiuddin M. Radiation therapy in the treatment of metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys. 1985;11(11):2007–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Gerszten PC, et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine. 2005;3(4):288–95.CrossRefPubMedGoogle Scholar
  43. 43.
    Nguyen QN, et al. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010;76(4):1185–92.CrossRefPubMedGoogle Scholar
  44. 44.
    Wersall PJ, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol. 2005;77(1):88–95.CrossRefPubMedGoogle Scholar
  45. 45.
    Maor MH, Frias AE, Oswald MJ. Palliative radiotherapy for brain metastases in renal carcinoma. Cancer. 1988;62(9):1912–7.CrossRefPubMedGoogle Scholar
  46. 46.
    Wronski M, et al. External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 1997;37(4):753–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Cannady SB, et al. Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Radiat Oncol Biol Phys. 2004;58(1):253–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Goyal LK, et al. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2000;47(4):1007–12.CrossRefPubMedGoogle Scholar
  49. 49.
    Culine S, et al. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer. 1998;83(12):2548–53.CrossRefPubMedGoogle Scholar
  50. 50.
    Samlowski WE, et al. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Cancer. 2008;113(9):2539–48.CrossRefPubMedGoogle Scholar
  51. 51.
    Mori Y, et al. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer. 1998;83(2):344–53.CrossRefPubMedGoogle Scholar
  52. 52.
    Schoggl A, et al. Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients. Acta Neurochir (Wien). 1998;140(6):549–55.CrossRefGoogle Scholar
  53. 53.
    Payne BR, et al. Gamma surgery for intracranial metastases from renal cell carcinoma. J Neurosurg. 2000;92(5):760–5.CrossRefPubMedGoogle Scholar
  54. 54.
    Brown PD, et al. Stereotactic radiosurgery for patients with “radioresistant” brain metastases. Neurosurgery. 2002;51(3):656–65. discussion 665–7.PubMedGoogle Scholar
  55. 55.
    Chang EL, et al. Outcome variation among “radioresistant” brain metastases treated with stereotactic radiosurgery. Neurosurgery. 2005;56(5):936–45. discussion 936–45.PubMedGoogle Scholar
  56. 56.
    Shiau CY, et al. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys. 1997;37(2):375–83.CrossRefPubMedGoogle Scholar
  57. 57.
    Marko NF, et al. Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases. World Neurosurg. 2010;73(3):186–93. discussion e29.CrossRefPubMedGoogle Scholar
  58. 58.
    Ikushima H, et al. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2000;48(5):1389–93.CrossRefPubMedGoogle Scholar
  59. 59.
    Muacevic A, Wowra B, Kreth FW. Radiosurgery in renal cell carcinoma. J Neurosurg. 2003;99(2):441.PubMedGoogle Scholar
  60. 60.
    Sheehan JP, et al. Radiosurgery in patients with renal cell carcinoma metastasis to the rain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg. 2003;98(2):342–9.CrossRefPubMedGoogle Scholar
  61. 61.
    Shuto T, et al. Gamma knife surgery for metastatic brain tumors from renal cell carcinoma. J Neurosurg. 2006;105(4):555–60.CrossRefPubMedGoogle Scholar
  62. 62.
    Wowra B, et al. Repeated gamma knife surgery for multiple brain metastases from renal cell carcinoma. J Neurosurg. 2002;97(4):785–93.CrossRefPubMedGoogle Scholar
  63. 63.
    Auchter RM, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996;35(1):27–35.CrossRefPubMedGoogle Scholar
  64. 64.
    Hoshi S, et al. Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: results in 42 patients. Int J Urol. 2002;9(11):618–25. discussion 626.Google Scholar
  65. 65.
    Noel G, et al. LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol. 2004;22(1):25–31.CrossRefPubMedGoogle Scholar
  66. 66.
    Pirzkall A, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol. 1998;16(11):3563–9.CrossRefPubMedGoogle Scholar
  67. 67.
    Powell JW, et al. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J Neurosurg. 2008;109(Suppl):122–8.PubMedGoogle Scholar
  68. 68.
    Schefter TE, et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005;62(5):1371–8.CrossRefPubMedGoogle Scholar
  69. 69.
    Kavanagh BD, Timmerman RD. Stereotactic body radiation therapy. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 159.Google Scholar
  70. 70.
    Moerland MA, et al. The influence of respiration induced motion of the kidneys on the accuracy of radiotherapy treatment planning, a magnetic resonance imaging study. Radiother Oncol. 1994;30(2):150–4.CrossRefPubMedGoogle Scholar
  71. 71.
    Schwartz LH, et al. Kidney mobility during respiration. Radiother Oncol. 1994;32(1):84–6.CrossRefPubMedGoogle Scholar
  72. 72.
    Bussels B, et al. Respiration-induced movement of the upper abdominal organs: a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer. Radiother Oncol. 2003;68(1):69–74.CrossRefPubMedGoogle Scholar
  73. 73.
    van Sornsen de Koste JR, et al. Renal mobility during uncoached quiet respiration: an analysis of 4DCT scans. Int J Radiat Oncol Biol Phys. 2006;64(3):799–803.CrossRefPubMedGoogle Scholar
  74. 74.
    Beitler JJ, et al. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol. 2004;27(6):646–8.CrossRefPubMedGoogle Scholar
  75. 75.
    Svedman C, et al. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncol. 2008;47(8):1578–83.CrossRefPubMedGoogle Scholar
  76. 76.
    Teh BS, Galli-Guevara M, Doh L, Richardson S, Chiang S, Yeh P, Gonzalez M, Lunn W, Marco R, Jac J, Paulino AC, Lu HH, Butler EB, Amato RJ. The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Intervent J. 2007;3:e6.Google Scholar
  77. 77.
    Teh BS, Chiang S, Richardson S, Butler EB, Amato R, Paulino AC. Genitourinary cancer. In: Paulino A, Teh BS, editors. PET-CT in radiotherapy treatment planning, Vol. Chapter 11. Philadelphia: Saunders Elsevier; 2008.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity of Texas Health Science Center at San AntonioSan AntonioUSA
  2. 2.Department of Radiation OncologyCancer Therapy and Research Center at the University of Texas Health Science CenterSan AntonioUSA

Personalised recommendations